Recruiting Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma NCT07300241 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more Locations NEO-811 Los Angeles Site — Duarte, California, United States NEO-811 San Diego Site — San Diego, California, United States NEO-811 Connecticut Site — New Haven, Connecticut, United States NEO-811 Chicago Site — Zion, Illinois, United States View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004) NCT03401788 Conditions Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +14 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States Massachusetts General Hospital — Boston, Massachusetts, United States University of Michigan — Ann Arbor, Michigan, United States University of Pennsylvania Medical Center — Philadelphia, Pennsylvania, United States View more locations Show fewer locations Loading locations... View Trial Details
